[go: up one dir, main page]

NO953322L - Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler - Google Patents

Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler

Info

Publication number
NO953322L
NO953322L NO953322A NO953322A NO953322L NO 953322 L NO953322 L NO 953322L NO 953322 A NO953322 A NO 953322A NO 953322 A NO953322 A NO 953322A NO 953322 L NO953322 L NO 953322L
Authority
NO
Norway
Prior art keywords
dihydropyridine
drugs
dicarboxylic acid
acid esters
esters
Prior art date
Application number
NO953322A
Other languages
English (en)
Other versions
NO953322D0 (no
Inventor
Klaus Urbahns
Otto Behner
Siegfried Goldmann
Hans-Georg Heine
Bodo Junge
Rudolf Schone-Loop
Egbert Wehinger
Hartmund Wollweber
Henning Sommermeyer
Thomas Glaser
Reilinde Wittka
Jean-Marie-Viktor De Vry
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO953322D0 publication Critical patent/NO953322D0/no
Publication of NO953322L publication Critical patent/NO953322L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO953322A 1994-08-25 1995-08-24 Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler NO953322L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430094A DE4430094A1 (de) 1994-08-25 1994-08-25 Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel

Publications (2)

Publication Number Publication Date
NO953322D0 NO953322D0 (no) 1995-08-24
NO953322L true NO953322L (no) 1996-02-26

Family

ID=6526498

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953322A NO953322L (no) 1994-08-25 1995-08-24 Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler

Country Status (14)

Country Link
US (2) US5665741A (no)
EP (1) EP0705819A1 (no)
JP (1) JPH0859468A (no)
KR (1) KR960007563A (no)
CN (1) CN1128757A (no)
AU (1) AU3011295A (no)
CA (1) CA2156673A1 (no)
DE (1) DE4430094A1 (no)
EE (1) EE9500055A (no)
FI (1) FI953957L (no)
HU (1) HUT74617A (no)
IL (1) IL115030A0 (no)
NO (1) NO953322L (no)
PL (1) PL310146A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078719A1 (en) * 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Dihydropyridine derivative
ATE511858T1 (de) * 2002-02-05 2011-06-15 Astellas Pharma Inc 2,4,6-triamino-1,3,5-triazin-derivat
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
AU2012342226B2 (en) * 2011-11-24 2017-09-28 Richter Gedeon Nyrt. 1,4- dihydropyridine derivatives with Hsp modulating activity
CN104710441B (zh) * 2014-12-18 2017-01-18 苏州科技学院 吡啶五甲酸二钾化合物及其制备方法
US20230416203A1 (en) * 2020-11-30 2023-12-28 Nanyang Technological University Potent and selective inhibitors of the calcium-activated potassium channel, kca3.1, for use as platform therapeutics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
US3883543A (en) * 1969-05-10 1975-05-13 Bayer Ag N-alkyl-1,4-dihydropyridines
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
JPS4899181A (no) * 1972-04-04 1973-12-15
DE2815578C2 (de) 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
EP0287828A1 (de) * 1987-03-27 1988-10-26 Byk Gulden Lomberg Chemische Fabrik GmbH Neue Zwischenprodukte und Verfahren
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PL310146A1 (en) 1996-03-04
FI953957A7 (fi) 1996-02-26
EE9500055A (et) 1996-04-15
US5665741A (en) 1997-09-09
FI953957L (fi) 1996-02-26
CN1128757A (zh) 1996-08-14
CA2156673A1 (en) 1996-02-26
JPH0859468A (ja) 1996-03-05
NO953322D0 (no) 1995-08-24
KR960007563A (ko) 1996-03-22
AU3011295A (en) 1996-03-07
IL115030A0 (en) 1995-12-08
US5955482A (en) 1999-09-21
HU9502509D0 (en) 1995-10-30
DE4430094A1 (de) 1996-02-29
FI953957A0 (fi) 1995-08-23
EP0705819A1 (de) 1996-04-10
HUT74617A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
ATE257846T1 (de) Herstellung von inulinhaltigen produkten
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
IT8848259A0 (it) 1,4-diidropiridine, loro procedimento di preparazione e loro applicazione come medicamenti
FI955498L (fi) Nipekotiinihappojohdannaisia hyytymistä estävinä aineina
NO951147D0 (no) Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel
FI931023A7 (fi) Uusia b-aminohappojohdannaisia
FI953956A0 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
NO953322L (no) Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler
FI941149A0 (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
FI923423A7 (fi) Uusia N-alkyloituja 1,4-dihydropyridiinidikarboksyylihappoestereitä
EP0673914A3 (en) Preparation of alpha-keto acid esters.
FI871316A7 (fi) Foerfarande foer framstaellning av acymmetriska esterderivat av 1,4-dihydropyridin-3,5-dikarboxylsyra.
FI933300L (fi) Foerfarande foer rengoering av klorvaetesyra i gasform
NO960777D0 (no) Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter
FI956016A7 (fi) 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina
FI20040352L (fi) Menetelmä 4-(3-syaanifenyyli)-trifluorimetyyli-5-okso-1,4,5,6,7,8-heksahydrokinoliini-3-karboksyylihapon valmistamiseksi
DE69705860D1 (de) Herstellung von adipinsäure
DE69817868D1 (de) 4-fluoro-3-oxocarbonsäureester und ihre herstellung
DE69502982D1 (de) Herstellung geschützter Aminothiazolylessigsäurederivate
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
DE69527684D1 (de) Herstellung von 3-oxy-5-oxo-6-Heptensäurederivaten
FI955825A7 (fi) Uusi, hyvin selektiivinen menetelmä enantiomeeripuhtaiden fenyylillä substituoitujen 1,4-dihydropyridiini-3,5-dikarboksyylihappojohdannaisten valmistamiseksi
FI932510A7 (fi) Uudet tiosemikarbatsonihappoesterit
FI933255A7 (fi) 1,4-dihydropyridiini-3,5-dikarboksyylihappoesteri, menetelmä sen valmistamiseksi ja sen farmaseuttinen käyttö
SE8505801D0 (sv) 1,4-dihydropyridin-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen